Follow
Michael H. Baumann
Michael H. Baumann
Intramural Research Program, National Institute on Drug Abuse
Verified email at mail.nih.gov
Title
Cited by
Cited by
Year
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
RB Rothman, MH Baumann, CM Dersch, DV Romero, KC Rice, FI Carroll, ...
Synapse 39 (1), 32-41, 2001
11462001
Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
RB Rothman, MH Baumann, JE Savage, L Rauser, A McBride, ...
Circulation 102 (23), 2836-2841, 2000
8462000
Monoamine transporters and psychostimulant drugs
RB Rothman, MH Baumann
European journal of pharmacology 479 (1-3), 23-40, 2003
6292003
The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue
MH Baumann, MA Ayestas, JS Partilla, JR Sink, AT Shulgin, PF Daley, ...
Neuropsychopharmacology 37 (5), 1192-1203, 2012
5212012
Powerful cocaine-like actions of 3, 4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products
MH Baumann, JS Partilla, KR Lehner, EB Thorndike, AF Hoffman, M Holy, ...
Neuropsychopharmacology 38 (4), 552-562, 2013
4932013
Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats
WA Carlezon, C Béguin, JA DiNieri, MH Baumann, MR Richards, ...
Journal of Pharmacology and Experimental Therapeutics 316 (1), 440-447, 2006
4792006
3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
MH Baumann, X Wang, RB Rothman
Psychopharmacology 189, 407-424, 2007
3092007
Misuse of novel synthetic opioids: a deadly new trend
MP Prekupec, PA Mansky, MH Baumann
Journal of addiction medicine 11 (4), 256-265, 2017
2792017
N-substituted piperazines abused by humans mimic the molecular mechanism of 3, 4-methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’)
MH Baumann, RD Clark, AG Budzynski, JS Partilla, BE Blough, ...
Neuropsychopharmacology 30 (3), 550-560, 2005
2602005
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension
RB Rothman, MA Ayestas, CM Dersch, MH Baumann
Circulation 100 (8), 869-875, 1999
2591999
Psychoactive “bath salts”: not so soothing
MH Baumann, JS Partilla, KR Lehner
European journal of pharmacology 698 (1-3), 1-5, 2013
2332013
Nitric oxide inhibits [3H] dopamine uptake
S Pogun, MH Baumann, MJ Kuhar
Brain research 641 (1), 83-91, 1994
2331994
Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3, 4-methylenedioxypyrovalerone (MDPV)
JA Marusich, KR Antonazzo, JL Wiley, BE Blough, JS Partilla, ...
Neuropharmacology 87, 206-213, 2014
2302014
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs
S Wee, KG Anderson, MH Baumann, RB Rothman, BE Blough, ...
Journal of Pharmacology and Experimental Therapeutics 313 (2), 848-854, 2005
2202005
Therapeutic and adverse actions of serotonin transporter substrates
RB Rothman, MH Baumann
Pharmacology & therapeutics 95 (1), 73-88, 2002
2142002
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil
D Zolkowska, R Jain, RB Rothman, JS Partilla, BL Roth, V Setola, ...
Journal of Pharmacology and Experimental Therapeutics 329 (2), 738-746, 2009
2112009
Interaction of amphetamines and related compounds at the vesicular monoamine transporter
JS Partilla, AG Dempsey, AS Nagpal, BE Blough, MH Baumann, ...
Journal of Pharmacology and Experimental Therapeutics 319 (1), 237-246, 2006
1892006
Serotonergic drugs and valvular heart disease
RB Rothman, MH Baumann
Expert opinion on drug safety 8 (3), 317-329, 2009
1582009
Serotonin releasing agents: neurochemical, therapeutic and adverse effects
RB Rothman, MH Baumann
Pharmacology Biochemistry and Behavior 71 (4), 825-836, 2002
1542002
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin
DC Mash, JK Staley, MH Baumann, RB Rothman, WL Hearn
Life sciences 57 (3), PL45-PL50, 1995
1521995
The system can't perform the operation now. Try again later.
Articles 1–20